AliveDx, MosaiQ

AliveDx amplía su menú de enfermedades autoinmunes con el ensayo multiplex MosaiQ AiPlex® CTDplus

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

AliveDx Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

View original content:https://www.prnewswire.com/news-releases/alivedx-amplia-su-menu-de-enfermedades-autoinmunes-con-el-ensayo-multiplex-mosaiq-aiplex-ctdplus-302366298.html

en | boerse | 67948640 |